| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6432974
[patent_doc_number] => 20020127644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/949654
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 165
[patent_figures_cnt] => 165
[patent_no_of_words] => 23283
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127644.pdf
[firstpage_image] =>[orig_patent_app_number] => 09949654
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/949654 | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | Sep 11, 2001 | Abandoned |
Array
(
[id] => 6655892
[patent_doc_number] => 20030077664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Methods of screening for compounds that modulate hormone receptor activity'
[patent_app_type] => new
[patent_app_number] => 09/922226
[patent_app_country] => US
[patent_app_date] => 2001-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27709
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077664.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922226
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922226 | Methods of screening for compounds that modulate hormone receptor activity | Aug 1, 2001 | Abandoned |
Array
(
[id] => 5908560
[patent_doc_number] => 20020143164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Ras activator nucleic acid molecules, polypeptides and methods of use'
[patent_app_type] => new
[patent_app_number] => 09/911826
[patent_app_country] => US
[patent_app_date] => 2001-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 20381
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20020143164.pdf
[firstpage_image] =>[orig_patent_app_number] => 09911826
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/911826 | Ras activator nucleic acid molecules, polypeptides and methods of use | Jul 19, 2001 | Abandoned |
Array
(
[id] => 6157532
[patent_doc_number] => 20020146709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/909088
[patent_app_country] => US
[patent_app_date] => 2001-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 125
[patent_figures_cnt] => 125
[patent_no_of_words] => 121679
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146709.pdf
[firstpage_image] =>[orig_patent_app_number] => 09909088
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/909088 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 17, 2001 | Abandoned |
Array
(
[id] => 6638840
[patent_doc_number] => 20030211985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Novel proteins and nucleic acids encoding same'
[patent_app_type] => new
[patent_app_number] => 09/908006
[patent_app_country] => US
[patent_app_date] => 2001-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72362
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211985.pdf
[firstpage_image] =>[orig_patent_app_number] => 09908006
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/908006 | Novel proteins and nucleic acids encoding same | Jul 17, 2001 | Abandoned |
Array
(
[id] => 6762211
[patent_doc_number] => 20030125573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Method of vitamin production'
[patent_app_type] => new
[patent_app_number] => 09/902187
[patent_app_country] => US
[patent_app_date] => 2001-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33781
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125573.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902187
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902187 | Method of vitamin production | Jul 8, 2001 | Abandoned |
| 09/806904 | Ion channels, in particular vanilloid receptor-like (vr-l ) receptor | Jul 1, 2001 | Abandoned |
| 09/868338 | Abc transporter and genes encoding the same | Jun 17, 2001 | Abandoned |
Array
(
[id] => 6538232
[patent_doc_number] => 20020137209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Methods of dissociating nongenotropic from genotropic activity of steroid receptors'
[patent_app_type] => new
[patent_app_number] => 09/880710
[patent_app_country] => US
[patent_app_date] => 2001-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 30563
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137209.pdf
[firstpage_image] =>[orig_patent_app_number] => 09880710
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/880710 | Methods of dissociating nongenotropic from genotropic activity of steroid receptors | Jun 12, 2001 | Abandoned |
| 09/786133 | Human membrane channel proteins | Jun 10, 2001 | Abandoned |
Array
(
[id] => 6064112
[patent_doc_number] => 20020032154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => ' Interferon-suppressing placental lactogen peptides'
[patent_app_type] => new
[patent_app_number] => 09/876478
[patent_app_country] => US
[patent_app_date] => 2001-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12680
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20020032154.pdf
[firstpage_image] =>[orig_patent_app_number] => 09876478
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/876478 | Interferon-suppressing placental lactogen peptides | Jun 6, 2001 | Abandoned |
Array
(
[id] => 6774844
[patent_doc_number] => 20030018182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Non-endogenous, constitutively activated human G protein-coupled receptors'
[patent_app_type] => new
[patent_app_number] => 09/876252
[patent_app_country] => US
[patent_app_date] => 2001-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17417
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018182.pdf
[firstpage_image] =>[orig_patent_app_number] => 09876252
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/876252 | Non-endogenous, constitutively activated human G protein-coupled receptors | Jun 6, 2001 | Abandoned |
Array
(
[id] => 6082298
[patent_doc_number] => 20020082210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => '56201, a novel human sodium ion channel family member and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/875363
[patent_app_country] => US
[patent_app_date] => 2001-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 43706
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082210.pdf
[firstpage_image] =>[orig_patent_app_number] => 09875363
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/875363 | 56201, a novel human sodium ion channel family member and uses thereof | Jun 4, 2001 | Abandoned |
Array
(
[id] => 6080853
[patent_doc_number] => 20020081720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Receptor activator of NF-kappaB'
[patent_app_type] => new
[patent_app_number] => 09/871856
[patent_app_country] => US
[patent_app_date] => 2001-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16523
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081720.pdf
[firstpage_image] =>[orig_patent_app_number] => 09871856
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/871856 | Receptor activator of NF-B | May 30, 2001 | Issued |
Array
(
[id] => 6636254
[patent_doc_number] => 20020086827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Receptor activator of NF-KappaB'
[patent_app_type] => new
[patent_app_number] => 09/871291
[patent_app_country] => US
[patent_app_date] => 2001-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16530
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086827.pdf
[firstpage_image] =>[orig_patent_app_number] => 09871291
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/871291 | Receptor activator of NF-B | May 29, 2001 | Issued |
Array
(
[id] => 5936097
[patent_doc_number] => 20020061590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => '38594, a novel human transporter and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/858194
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 41355
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061590.pdf
[firstpage_image] =>[orig_patent_app_number] => 09858194
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/858194 | 38594, a novel human transporter and uses thereof | May 13, 2001 | Abandoned |
Array
(
[id] => 6501030
[patent_doc_number] => 20020025555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'GPCR diagnostic for brain cancer'
[patent_app_type] => new
[patent_app_number] => 09/848889
[patent_app_country] => US
[patent_app_date] => 2001-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16833
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025555.pdf
[firstpage_image] =>[orig_patent_app_number] => 09848889
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/848889 | GPCR diagnostic for brain cancer | May 2, 2001 | Abandoned |
Array
(
[id] => 6886733
[patent_doc_number] => 20010020002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-06
[patent_title] => 'Androgen activity antagonists as therapies for anorexia, anorexia nervosa and disorders characterized by a pathologically underweight condition'
[patent_app_type] => new
[patent_app_number] => 09/834468
[patent_app_country] => US
[patent_app_date] => 2001-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9160
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20010020002.pdf
[firstpage_image] =>[orig_patent_app_number] => 09834468
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/834468 | Androgen activity antagonists as therapies for anorexia, anorexia nervosa and disorders characterized by a pathologically underweight condition | Apr 12, 2001 | Abandoned |
Array
(
[id] => 5936592
[patent_doc_number] => 20020061847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Methods and compositions utilizing an alternative splice variant of the sigma-1 receptor'
[patent_app_type] => new
[patent_app_number] => 09/823069
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14634
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061847.pdf
[firstpage_image] =>[orig_patent_app_number] => 09823069
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/823069 | Methods and compositions utilizing an alternative splice variant of the sigma-1 receptor | Mar 29, 2001 | Issued |
| 09/820802 | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | Mar 29, 2001 | Abandoned |
